谷歌浏览器插件
订阅小程序
在清言上使用

MPN-334 Safety and Efficacy of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (advsm): Results from Part 1 of the Phase 2 Apex Trial

Pankit Vachhani,Tsewang Tashi,Gary Schiller,Stephanie Lee, Miguel,Helena Pomares,Cristina Bulai Livideanu,Jonathan Lambert,Anthony M. Hunter, Tracy I. George, Jay Patel,Daniel J. DeAngelo, Cristina Papayannidis,Khalid Shoumariyeh,Ben Exter, Lei Sun,Jenna Zhang, LouAnn Cable,Amanda Pilla,Hina A. Jolin,Rachael Easton, Marcus Carden, Vinod Pullarkat

Clinical Lymphoma Myeloma and Leukemia(2024)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要